Navigation Links
Patients Not Complying With Their Dermatologic Problem

!

Patient forgetfulness is just one part of the problem, he said. Sometimes, patients consider treatment the worst part of the disease. For example, scalp psoriasis may seem resistant to treatment, he said. Actually, psoriasis treatments probably work better on the scalp than on other areas of the skin, if patients would just apply the medication.

Rather than having patients continually try new treatments for scalp psoriasis, he suggests having patients try the treatment for three to four days.

It is much easier to be compliant for three or four days than for eight weeks, Feldman said. After that, patients will know they have a treatment that works and will use it as needed to keep their scalp psoriasis under control.

He said that when prescribing medications, physicians need to consider which form is most likely to be used. Many patients prefer pills over creams and ointments, he said. Another option is physician-administered treatments, such as injections, that will assure adherence.

Feldman says doctors shouldnt be surprised by poor adherence to using creams and ointments in the home environment, especially involving pediatric patients.

Those of us who are parents will recognize how difficult it is to apply sunscreen or other topical agents to our own children, he said. In addition to considering the form of therapy that patients are most likely to use, Feldman said the patient-physician relationship is an important part of the equation.

He said research shows that if patients are satisfied with their physician visit three days afterwards, they are more likely to report an improvement in their condition a month later.

Patients who are more satisfied with their visit are more trusting of their doctor, worry less about adverse effects and use their medication more regularly, he said.

Media Contacts: Karen Richardson, krchrdsn@wfubmc.edu; S
'"/>




Page: 1 2 3

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
(Date:12/2/2008)... The Health Story Project was anno...formerly known as “Clinical Document Archite...CDA4CDT will continue as the label for the technic...d to Health Level Seven (HL7) for ballot. The new ...Wire EON) December 2, 2008 -- "Our group has...
(Date:12/2/2008)...OR, Mich.---Older people tend to feel about 13 yea...is one of the findings of a study forthcoming in t... . The researchers analyzed the responses of 516 m...the Berlin Aging Study, tracking how their percept...hanged over a six-year period. , "People general...
(Date:12/2/2008)...elease is available in French . , Deep venous... the lower limbs, is the third-most common vascula...stroke, and is a frequent complication in hospital...ion that can lead to rapid death from pulmonary em... health concern that the U.S. Surgeon General and ...
(Date:12/2/2008)... WASHINGTON, Dec. 2 ...l deliver the Keynote address at eHealth Initiativ... the Pulse of Health IT: A Critical Review of Prog...ons for 2009 and Beyond." , , (Logo: http:..., , The Keynote speech will begin at 4:30 p...
Breaking Medicine News(10 mins):Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5Health News:Old as you want to be: Study finds most seniors feel younger 2Health News:Thrombosis patients face greater risks than previously believed 2
... which is causing confusion among scientists, //...the scientist work overtime to decipher the reason...ive, queen bee, food and the young. Many years ag... leave the hive to be ransacked by honey bees from...
...could not seem to keep up with the other children ...hings compared to the other children. Her running ...ses it was found that she has CMT, Charcot-Marie-T...nd that her father and her brother Tony too suffer...
... tract infection. Wan et al reviewed //the clinica... and treatment. This study is important since urin...es of unexplained fevers in infants with an overal... 10%. All the patients in this study underwent ren...
...s interfere with the therapeutic effects of chemot...review of the use of antioxidants during chemother...s, tumor response, and the patient’s ability to to...mplications for patients whose oncologists discour...
Other Medicine News:Health News:Vanishing Honey Bees 2Health News:Cure for CMT 2Health News:Antioxidants May Aid Chemotherapy Patients 2
(Date:12/2/2008)...c. 2 Horizon Therapeutics, Inc., a...announced that two pivotal,Phase 3 trials evaluat...T-501,met all primary endpoints. HZT-501, a nove...taining ibuprofen and famotidine, demonstrated a,...ce of non-steroidal,anti-inflammatory drug (NSAID...
(Date:12/1/2008)... CHICAGO, Dec. 2 A stu...EM), a new technique for imaging the breast, is no...ormonal status, two factors that limit the effecti...g cancer. Results will be presented today at the a... America (RSNA). , , "The ability of PEM t...
(Date:12/1/2008)...1 S*BIO Pte Ltd today announced th...18, a potent and orally-active JAK2 inhibitor, in ...with chronic idiopathic myelofibrosis (CIMF). , ...ty and tolerability of SB1518 in patients with CIM... Phase 1 part of the study will assess the safety ...
(Date:12/1/2008)...hows the Prox1 gene is a two-way switch that, if t...e reprogrammed so that they lose their identity an..., MEMPHIS, Tenn., Dec. 1 /PRNewswire-USNewswire/...spital have discovered that a certain differentiat...at it requires the constant expression of a gene c...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 1JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 2JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 3Kowa Company Ltd Acquires ProEthic Pharmaceuticals Inc 6913 1Kowa Company Ltd Acquires ProEthic Pharmaceuticals Inc 6913 2Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 1Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 2Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 3Huifeng Bio Pharmaceutical 28HFGB 29 to Release Second Quarter 2008 Earnings Results on August 15 2008 6904 1
...ion during the,early post-operative period compare...ion in nausea in the female,patient population com... CeNeS Pharmaceuticals plc (AIM:,CEN), the Cambrid...tional data from post-hoc analysis of the recent P...nide) in over 500 patients,with post-operative pai...
...0%; mso-hyphenate: none">,BUDAPEST, Hungary, June,...sands of patients with cancer from suffering,unnec...ngress of,the European Association for Palliative ...ated whether this first in class novel,formulation...,duration of effect, mirroring the breakthrough pa...
Other Medicine Technology:Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: